T Cell Response in Hypersensitivity Syndrome

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University Hospital, Rouen
ClinicalTrials.gov Identifier:
NCT00213447
First received: September 13, 2005
Last updated: June 17, 2013
Last verified: June 2013
  Purpose

immunological study of the T cell repertoire phenotype and functionality in hypersensitivity syndrome.


Condition
Hypersensitivity
Syndrome

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Characterization of T Cell Response in Hypersensitivity Syndrome

Resource links provided by NLM:


Further study details as provided by University Hospital, Rouen:

Estimated Enrollment: 40
Study Start Date: November 2002
Estimated Study Completion Date: December 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patients with Drug rash with eosinophilia and systemic symptoms

Criteria

Inclusion Criteria:

  • age > 18
  • cutaneous eruption
  • lymph nodes
  • hepatitis
  • interstitial pneumonia
  • nephritis
  • cardiopathy
  • eosinophilia
  • hyperlymphocytosis

Exclusion Criteria:

  • age minor to 18
  • HIV +
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00213447

Locations
France
UH-Rouen
Rouen, France
Sponsors and Collaborators
University Hospital, Rouen
Investigators
Principal Investigator: Pascal Joly, MD-PHD UH rouen
  More Information

No publications provided by University Hospital, Rouen

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University Hospital, Rouen
ClinicalTrials.gov Identifier: NCT00213447     History of Changes
Other Study ID Numbers: 2001/056/HP
Study First Received: September 13, 2005
Last Updated: June 17, 2013
Health Authority: France: Ministry of Health

Additional relevant MeSH terms:
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on April 22, 2014